LNPEP and type 1 diabetes mellitus: On the contrary, acute single administration of IRAP inhibitor HFI-419 did not affect peripheral whole-body glucose handling during the glucose and insulin tolerance tests, neither in control rats nor in the streptozotocin-induced experimental rat model of diabetes mellitus type I (Albiston et al., 2017).